Hjem › Makuladegenerasjon › Massachusetts
Kliniske studier for Makuladegenerasjon i Massachusetts
14 studier for Makuladegenerasjon søker deltakere på steder i Massachusetts.
Byer i Massachusetts
Offisiell studietekst (engelsk)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Ophthalmic Consultants of Boston, Boston
RekruttererFase 2/3
Alder 60 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06635148A Study in Adults With Geographic Atrophy
- Ophthalmic Consultants of Boston, Waltham
RekruttererFase 2
Alder 60 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Massachusetts Eye And Ear Infirmary, Boston
- Opthalmic Consultants of Boston, Boston
- New England Retina Consultants, PC, Springfield
- og 2 flere
RekruttererFase 3
Alder 50 til 85 · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Retina Research Institute at New England Retina Consultants, Springfield
RekruttererFase 2
Alder 55 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Ophthalmic Consultants of Boston, Boston
RekruttererFase 1
Alder 50 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT03178149A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
- Ophthalmic Consultants of Boston, Boston
RekruttererObservasjonsstudie
Alder 50 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT063466004D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Ophthalmic Consultants of Boston & Boston Eye Surgery and Laser Center, Boston
RekruttererFase 1/2
Alder 50 og eldre · Alle kjønn · Oppdatert 21. aug. 2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Retina Research Institute at New England Retina Consultants, PC, Springfield
RekruttererFase 2/3
Alder 50 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT07496567Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
- Ophthalmic Consultants of Boston, East Weymouth
RekruttererFase 1
Alder 50 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT07230834The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma
- MCPHS 10 Lincoln Square, Worcester
RekruttererTidlig fase 1Frivillige helsepersonell ønskes velkommen
Alder 50 til 100 · Alle kjønn · Oppdatert 12. mai 2026 · NCT06593405Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss
- New England College of Optometry, Boston
Rekrutterer
Alder 14 og eldre · Alle kjønn · Oppdatert 11. mai 2026 · NCT07577219Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- New England Retina Consultants, Springfield
RekruttererFase 3
Alder 50 og eldre · Alle kjønn · Oppdatert 16. apr. 2026 · NCT07064759Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
- Massachusetts Eye and Ear Infirmary, Boston
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 26. jan. 2026 · NCT04735263Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Tallman Eye Associates, Lawrence
Rekrutterer
Alder 65 og eldre · Alle kjønn · Oppdatert 3. des. 2024 · NCT05438732Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.